vers la météo de la validation par utilisateur

Ingenuity291

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 84 - PMID ?

In primary culture __SP__ myoblasts , __NODE__ ( with a dosage of 110.5 mcmolar and a treatment period of 4 days ) decreases ( by 410.7 percent ) expression of __SP__ __NODE__ mRNA .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
               +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                              
               |                           +----------------------------------SUBJ:V-N----------------------------------+------------OBJ:V-N------------+-------COMP:N-N(of)-------+   
               +----OBJ:V-N----+           +--------------------------APPOS-------------------------+COMP:N-N(o+        +----COMP:V-N(by)---+           |           +-MOD_ATT:N-ADJ+   
       +MOD_ATT+       +SUBJ:V-+           |                +COMP:N-N+                     +MOD_ATT:+      +MOD+        |            +MOD_AT+           |           |       +MOD_AT+   
       |       |       |       |           |                |        |                     |        |      |   |        |            |      |           |           |       |      |   
 In primary culture __SP__ myoblasts , __NODE__ ( with a dosage of 110.5 mcmolar and a treatment period of 4 days ) decreases ( by 410.7 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (culture,primary)
OBJ:V-N (myoblasts,culture)
SUBJ:V-N (myoblasts,__SP__)
APPOS (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,4)
COMP:V-N(In) (decrease,culture)
SUBJ:V-N (decrease,__NODE__)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 1 
               +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                              
               |                           +----------------------------------SUBJ:V-N----------------------------------+------------OBJ:V-N------------+-------COMP:N-N(of)-------+   
               +----OBJ:V-N----+           +--------------------------APPOS-------------------------+COMP:N-N(o+        +----COMP:V-N(by)---+           |           +-MOD_ATT:N-ADJ+   
       +MOD_ATT+       +SUBJ:V-+           |                +COMP:N-N+                     +MOD_ATT:+      +MOD+        |            +MOD_AT+           |           |       +MOD_AT+   
       |       |       |       |           |                |        |                     |        |      |   |        |            |      |           |           |       |      |   
 In primary culture __SP__ myoblasts , __NODE__ ( with a dosage of 110.5 mcmolar and a treatment period of 4 days ) decreases ( by 410.7 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-ADJ (culture,primary)
OBJ:V-N (myoblasts,culture)
SUBJ:V-N (myoblasts,__SP__)
APPOS (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,4)
COMP:V-N(In) (decrease,culture)
SUBJ:V-N (decrease,__NODE__)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
Analyse 2 
                               +--------------------------------------COMP:V-N(In)--------------------------------------+                                                              
       +------MOD_ATT:N-N------+           +----------------------------------SUBJ:V-N----------------------------------+------------OBJ:V-N------------+-------COMP:N-N(of)-------+   
       |       +--MOD_ATT:N-N--+           +--------------------------APPOS-------------------------+COMP:N-N(o+        +----COMP:V-N(by)---+           |           +-MOD_ATT:N-ADJ+   
       |       |       +MOD_ATT+           |                +COMP:N-N+                     +MOD_ATT:+      +MOD+        |            +MOD_AT+           |           |       +MOD_AT+   
       |       |       |       |           |                |        |                     |        |      |   |        |            |      |           |           |       |      |   
 In primary culture __SP__ myoblasts , __NODE__ ( with a dosage of 110.5 mcmolar and a treatment period of 4 days ) decreases ( by 410.7 percent ) expression of __SP__ __NODE__ mRNA .
MOD_ATT:N-N (myoblasts,primary)
MOD_ATT:N-N (myoblasts,culture)
MOD_ATT:N-ADJ (myoblasts,__SP__)
APPOS (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,4)
COMP:V-N(In) (decrease,myoblasts)
SUBJ:V-N (decrease,__NODE__)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,expression)
MOD_ATT:N-ADJ (percent,@card@)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)